Sign inJoin free

Watch / Stock Selection

Stuart baulks at this burrito

21 June 20247:19

Stuart baulks at this burrito

General information only. ausbiz videos are general information only, produced by Ausbiz TV Pty Ltd, a media business that doesn’t give financial advice. They don’t take into account your objectives, financial situation or needs. Consider whether it’s right for you and read the PDS and TMD before acting on anything you watch.

About this video

Key points:

  • Stuart Roberts expresses concern over Guzman and Gomez's high valuation

  • He brings attention to pressures from cost of living and customer shifts in consumer sentiment

  • He advocates for consideration of Botanics Pharmaceuticals

Stuart Roberts from Stocks Down Under gives his take on the newly public company, Guzman Y Gomez (ASX: GYG). He admits to being a patron himself but expresses concern over the company's high valuation, comparing it to Domino's (ASX: DMP) and highlighting its pricey quick service restaurant format. Despite the restaurant chain being well-executed, Stuart considers it overpriced, and anticipates more decline after an initial drop of 5%.

Stuart further discusses the vulnerability of the company in the face of consumer shifts like those seen with Domino's (ASX: DMP). He remarks that cost of living pressures can redirect customers to long-standing reliable outlets such as McDonald's. Stuart also feels sceptical of Guzman's (ASX: GYG) high-growth projections given their current climate of consumer sentiment and living costs.

Lastly, Stuart brings attention to Botanix Pharmaceuticals (ASX: BOT), a company he finds lacks the recognition it deserves despite its FDA approved drug for an underserved medical condition. He encourages investors who profited from Guzman (ASX: GYG) to consider investing in Botanix Pharmaceuticals (ASX: BOT). Despite acknowledging the potential for Guzman's (ASX: GYG) success, as was the unexpected case for Starbucks years ago, Stuart maintains his reservations about the company's valuation.

Below is an unedited transcript of the interview:

0:00

Let's, um, dig a little deeper. Take a bigger bite, if you like, out of Guzman and Gomez. Stuart Roberts joining us from Stockton under. Uh, it lends itself to, uh, a bit of, uh,

0:13

some of the metaphors we're using at the moment isn't as far as Guzman and Gomez. So what did you make of that, Stuart? Because, uh, highly anticipated a lot of chatter about whether just how overvalued it was. But then we saw what happened yesterday. So what's going on? Basically, a lot of people have eaten at Guzman and Gomez over the years, and they've enjoyed the experience. Uh, my business partner and I regularly have lunch, uh, at Guzman and Gomez in the outlet near where our office is. What's the old Peter Lynch rule? If you've experienced the product firsthand, uh, you're more likely to understand and understand the dynamics. Well, um. Uh, fair enough, but this is crazy. Uh, Guzman and Gomez is at $3 billion yesterday. Uh, well, 3.3 enterprise value, around $3 billion. That's an EV to EBITDA of 46 times, which is absolutely crazy. So down 5% this morning, I predict there's more where that where that came from. And and I'd be I'd be very cautious at these points. But it's it's illustrative of how once buzz gets around an idea, everyone likes to buy in on that idea.

1:13

And, and then you get these, these kind of, uh, spikes in interest in a particular theme. How? I mean, it goes at that point, I guess, when it comes to like, Lisa, I mean, how do you value it? Well, um, Domino's is at 12, so, uh, so, okay, Domino's has probably got less growth than, than than Guzman Gomez. And do you have lunch at Domino's? Well, I do look, I'm, I'm a I'm, I'm not fussy about about where I eat. I've even been known. Please don't tell my friends, but I've been known to eat a McDonald's every now and then, for example. Um, uh, but let me let me tell you what my big concern is with Guzman. It's my wife's birthday this weekend. And I said, where do you want to? What do you want to go? To dine out to celebrate your birthday. And I was crossing my fingers, hoping she wouldn't say Guzman and Gomez, because that would have cost me a fortune to

1:58

watch. Her taste may be a little better than that, Stuart. No, I can assure you it'll be a nice dinner. But it won't be Guzman and Gomez. And thank heavens, because that's an expensive, quick service restaurant format. Just just the the actual merchandise in the stores. And remember, we're in a cost of living crisis right now. Yeah. And the big villain at the moment, the reason why inflation is stubbornly high in our country compared to others is, is food prices. Um, so I think we're very vulnerable to, to to the, the bean counters at the reserve Bank, uh, trying to squeeze things a little harder. And that that puts the potential for Guzman and Gomez to miss their earnings. And remember, they've been very aggressive for FY 24. They'll do 25 million in pro forma EBITDA. They expect to jump to 60 in FY 25. So that's quite an aggressive growth operating now it is a franchise. So it can scale well if it scales. But this one is priced to perfection. So I would be I would be a little worried. The other factor is competition. Did you know that Guzman and Gomez is not the biggest Mexican restaurant in Australia? Apparently so. In fact, I was

2:58

reading that column in the Finn today. Right, Sam? Sam, Prince of Zambia, and I've had the privilege of meeting Sam in the past. Yeah, not nearly as hyped as Goodman Gomez is and probably trades in the private market at less. It's my made him one of the wealthiest. But you ask me where those restaurants are, I wouldn't have a clue. Right? Okay, so look, don't get me wrong, this this company has been exceptionally well executed as it's as it's grown and it's using all the playbook you want to get from from the QSR, the digital app, the fact that they're encouraging people to go there for, for for breakfast, it's more of a drive by type opportunity than going to the store. Uh, it works quite well in all those those respects. It just it's just expensive. And really, what tripped up Domino's uh, once it was the price of cheese at one stage was too high last time. They then then suddenly people in Japan stopped eating pizza. The most recent one was people didn't want to pay the delivery fee to get the pizza there. The Guzman and Gomez are in the in the same, uh, market segment, if you like. So they're just as vulnerable to these sudden shifts in consumer

3:58

sentiment, uh, like what we saw in Domino's last year. But what do we what does history show when the consumer is under pressure with cost of living? Do they do their scale back, you know, their visits to these quick service restaurants? They, uh, they're likely to, to shift back to the reliable ones they know. And McDonald's has been with us since the 1960s and and it's fairly reliable. So I'd be concerned about a shift back to the, to the, the people who pioneered this category in a, in a previous generation is what I'm thinking. What do you make of Guzman's ambitious expansion plans? Well, um, uh, that, that that's part of the reason why there's some excitement there. There's plenty of sites that have scoped out. There are only about 200 stores now. They want to get to 1000 a few years time. So every couple of weeks there'll be a new a new franchise opening somewhere. And I imagine that that people will be interested in becoming franchisees. So there's no doubt that they can roll that out. Domino's proved you can grow a pretty successful franchise quite quickly, but it's all the other extraneous factors that could come

4:58

in and racket and. One of those things has got to be, um, uh, the the sudden shifts in consumer sentiment, in the kind of cost of living crisis that we're, that we're going through. Um. Oh, look, let me let me share with you one other insight as well. Um, uh, all the chatter and Guzman and Gomez, I didn't hear one peep out of the commentariat about a little company called Botanics Pharmaceuticals. I bet that's been talked about all week. They've just got FDA approval for for a new drug. They kept it about one sixth of the market capitalization of of Guzman and Gomez. They've got a drug that can treat 10 million people. Um, it treats a condition called primary axillary hyperhidrosis. I hope you don't have that. But there's about 10 million people who have that condition. That

5:45

excessive sweating in the in the, in the in the underarm glands. Um, and and this is the first genuine, uh, underlying mechanism of action this thing works treatment to, to to stop this condition. It's one of those rare opportunities where effectively you're inventing a new, a new a new drug category for something that people didn't think was, was treatable before. Now that you know, it's treatable and you get everything else is good about pharmaceuticals, uh, high margins, uh, a customer base that doesn't shift around because this is the only, the only opportunity and some pretty motivated, motivated consumers at the other end. Um, uh, if, um, if you've made money out of Guzman and Gomez, I'd move on now and take a look at. But potential pharmaceuticals, because that one could have a lot more life than Guzman in it. All right. So you're saying look, look for that real potential for growth. And so you clearly have your doubts about Guzman and particularly that valuation at the moment. Right. Um, I won't say it's necessarily going to sink overnight, but I'm concerned now the let me give you the

6:44

counterargument as well. Next week, we will celebrate the 34th anniversary of the Starbucks IPO. June 26th, 1992. They went public. I remember the commentary at the time. That's ridiculous. The valuation that Starbucks is going at, they just sell coffee. Well, that was you know, the naysayers were proved wrong. Um, for those people who want to stay in Guzman and Kobe's drug, they're hoping I'll be proven wrong on on on that stock, but I'm not so sure. Well, it might be a little bit different, though. Australians, you know, being snobs in terms of coffee never really got off of Starbucks, have they? Right, right. So so yeah. So watch out if Guzman starts introducing Starbucks style coffee into their stores.

More like this

We value your privacy

We use essential cookies to make the site work. Non-essential cookies help us improve the experience. You can accept or reject non-essential cookies. Privacy policy